Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$191.51 - $216.16 $1.16 Million - $1.31 Million
6,074 Added 4.39%
144,298 $30.6 Million
Q2 2023

Aug 04, 2023

BUY
$187.64 - $206.25 $23.2 Million - $25.5 Million
123,769 Added 856.24%
138,224 $26.6 Million
Q1 2023

May 08, 2023

BUY
$127.59 - $203.08 $1.84 Million - $2.94 Million
14,455 New
14,455 $2.93 Million
Q2 2022

Aug 12, 2022

BUY
$108.81 - $179.33 $125,784 - $207,305
1,156 New
1,156 $205,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.